CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30718% above fair value
$6.47+0.44 (+7.30%)
Close on Nov 16, 2026Market cap $323.80MP/E –Yield –
CapsoVision profit margin
Profit margin (net margin) is net income as a percentage of revenue.
CapsoVision's profit margin for the twelve months ending Jun 30, 2026 was -214.7%. For fiscal 2025 it was -186.8%, against -169.3% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -186.8% | −17.5 |
| FY2024 | Dec 31, 2024 | -169.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -205.4% | −65.8 |
| Q1 FY2026 | Mar 31, 2026 | -251.9% | −58.8 |
| Q4 FY2025 | Dec 31, 2025 | -188.7% | −54.3 |
| Q3 FY2025 | Sep 30, 2025 | -223.9% | −28.5 |
| Q2 FY2025 | Jun 30, 2025 | -139.5% | +45.7 |
| Q1 FY2025 | Mar 31, 2025 | -193.1% | – |
| Q4 FY2024 | Dec 31, 2024 | -134.4% | – |
| Q3 FY2024 | Sep 30, 2024 | -195.3% | – |
| Q2 FY2024 | Jun 30, 2024 | -185.2% | – |
See a number that looks wrong?